BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30734017)

  • 1. International benchmarking in oesophageal and gastric cancer surgery.
    Busweiler LAD; Jeremiasen M; Wijnhoven BPL; Lindblad M; Lundell L; van de Velde CJH; Tollenaar RAEM; Wouters MWJM; van Sandick JW; Johansson J; Dikken JL
    BJS Open; 2019 Feb; 3(1):62-73. PubMed ID: 30734017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in outcomes of oesophageal and gastric cancer surgery across Europe.
    Dikken JL; van Sandick JW; Allum WH; Johansson J; Jensen LS; Putter H; Coupland VH; Wouters MW; Lemmens VE; van de Velde CJ; van der Geest LG; Larsson HJ; Cats A; Verheij M
    Br J Surg; 2013 Jan; 100(1):83-94. PubMed ID: 23180474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery.
    Dikken JL; Wouters MW; Lemmens VE; Putter H; van der Geest LG; Verheij M; Cats A; van Sandick JW; van de Velde CJ
    Br J Surg; 2012 Jul; 99(7):954-63. PubMed ID: 22569956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009.
    Dikken JL; Dassen AE; Lemmens VE; Putter H; Krijnen P; van der Geest L; Bosscha K; Verheij M; van de Velde CJ; Wouters MW
    Eur J Cancer; 2012 May; 48(7):1004-13. PubMed ID: 22456179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Textbook outcome as a composite measure in oesophagogastric cancer surgery.
    Busweiler LA; Schouwenburg MG; van Berge Henegouwen MI; Kolfschoten NE; de Jong PC; Rozema T; Wijnhoven BP; van Hillegersberg R; Wouters MW; van Sandick JW;
    Br J Surg; 2017 May; 104(6):742-750. PubMed ID: 28240357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
    Busweiler LA; Henneman D; Dikken JL; Fiocco M; van Berge Henegouwen MI; Wijnhoven BP; van Hillegersberg R; Rosman C; Wouters MW; van Sandick JW;
    Eur J Surg Oncol; 2017 Oct; 43(10):1962-1969. PubMed ID: 28797755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
    van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
    Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery.
    van der Kaaij RT; de Rooij MV; van Coevorden F; Voncken FEM; Snaebjornsson P; Boot H; van Sandick JW
    Br J Surg; 2018 Apr; 105(5):561-569. PubMed ID: 29465746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Schouwenburg MG; Busweiler LAD; Beck N; Henneman D; Amodio S; van Berge Henegouwen MI; Cats A; van Hillegersberg R; van Sandick JW; Wijnhoven BPL; Wouters MWJ; Nieuwenhuijzen GAP;
    Eur J Surg Oncol; 2018 Apr; 44(4):532-538. PubMed ID: 29439836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.
    Coupland VH; Lagergren J; Lüchtenborg M; Jack RH; Allum W; Holmberg L; Hanna GB; Pearce N; Møller H
    Gut; 2013 Jul; 62(7):961-6. PubMed ID: 23086798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review.
    Markar SR; Wiggins T; Ni M; Steyerberg EW; Van Lanschot JJ; Sasako M; Hanna GB
    Lancet Oncol; 2015 Jan; 16(1):e23-31. PubMed ID: 25638550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit.
    Busweiler LA; Wijnhoven BP; van Berge Henegouwen MI; Henneman D; van Grieken NC; Wouters MW; van Hillegersberg R; van Sandick JW;
    Br J Surg; 2016 Dec; 103(13):1855-1863. PubMed ID: 27704530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk adjustment models for short-term outcomes after surgical resection for oesophagogastric cancer.
    Fischer C; Lingsma H; Hardwick R; Cromwell DA; Steyerberg E; Groene O
    Br J Surg; 2016 Jan; 103(1):105-16. PubMed ID: 26607783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit.
    van der Werf LR; Dikken JL; van Berge Henegouwen MI; Lemmens VEPP; Nieuwenhuijzen GAP; Wijnhoven BPL;
    Ann Surg Oncol; 2018 May; 25(5):1211-1220. PubMed ID: 29524046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
    Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
    Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival.
    Kauppila JH; Wahlin K; Lagergren J
    Sci Rep; 2017 Dec; 7(1):17783. PubMed ID: 29259274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery of gastric cancer and esophageal cancer: Does age matter?
    Nienhueser H; Kunzmann R; Sisic L; Blank S; Strowitzk MJ; Bruckner T; Jäger D; Weichert W; Ulrich A; Büchler MW; Ott K; Schmidt T
    J Surg Oncol; 2015 Sep; 112(4):387-95. PubMed ID: 26303645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.